Neutralizing antibodies induced by IpaB and IpaC mRNA vaccines inhibit Shigella flexneri invasion
Microbiology Spectrum · 2025
DOI: 10.1128/spectrum.00993-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Ye-Eun Moon und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences and Technology, GAIHST, Gachon University, Incheon, Korea. Hauptthemen laut MEDLINE: Shigella flexneri, Dysentery, Bacillary, Shigella Vaccines, Antibodies, Neutralizing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gachon University, Ministry of Food and Drug Safety.
Abstract (Originalsprache)
Shigellosis, caused by Shigella species, remains a significant global health burden due to its high morbidity and mortality, particularly in developing countries, and frequent antimicrobial resistance. Thus far, various Shigella vaccine candidates have been tested, but many have shown limited immunogenicity, high reactogenicity, or insufficient cross-serotype protection due to serotype-specific O-polysaccharide (OPS) targeting. In this study, we evaluated mRNA vaccine candidates targeting the highly conserved Shigella invasion plasmid antigens (IpaB and IpaC), aiming to provide a preventive strategy that can address various serogroups of Shigella . Using a mouse intraperitoneal infection model, we assessed the immune responses and protective efficacy of lipid nanoparticle (LNP)-encapsulated mRNA vaccines. The results demonstrated that the vaccine induced neutralizing antibodies capable of inhibiting intracellular invasion by Shigella flexneri , confirming its potential for protection against this serotype. IMPORTANCE This study aimed to utilize mRNA vaccine technology targeting conserved antigens (IpaB and IpaC) to overcome the limitations of previous Shigella vaccines. By demonstrating functional immune responses against Shigella flexneri , our findings suggest that mRNA vaccines may serve as a preventive strategy against Shigella infection and contribute to the foundation for future research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health Sciences and Technology, GAIHST, Gachon University, Incheon, Korea.
- Department of Bio-medical Sciences, GAIHST, Gachon University, Incheon, Korea.
- Department of Life Science, Gachon University, Seongnam, Korea.
- Department of Microbiology, Gachon University, Incheon, Korea.
- Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon, Korea.
- Korea mRNA Vaccine Initiative, Gachon University, Seongnam, Korea.
ORCID-Profile: Ye-Eun Moon, Pil-Gu Park
Förderung
- Gachon University
- Ministry of Food and Drug Safety
Zitieren
APA
Moon, Y. E., An, T., Park, P. G., & Hong, K. J. (2025). Neutralizing antibodies induced by IpaB and IpaC mRNA vaccines inhibit Shigella flexneri invasion. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00993-25
Vancouver
Moon YE, An T, Park PG, Hong KJ. Neutralizing antibodies induced by IpaB and IpaC mRNA vaccines inhibit Shigella flexneri invasion. Microbiology Spectrum. 2025. doi:10.1128/spectrum.00993-25
BibTeX
@article{Moon2025,
author = {Moon, Ye-Eun and An, Timothy and Park, Pil-Gu and Hong, Kee-Jong},
title = {Neutralizing antibodies induced by IpaB and IpaC mRNA vaccines inhibit Shigella flexneri invasion},
journal = {Microbiology Spectrum},
year = {2025},
doi = {10.1128/spectrum.00993-25}
}
EUVIMED